HEADER HYDROLASE 18-APR-16 5JED TITLE APO-STRUCTURE OF HUMANISED RADA-MUTANT HUMRADA28 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DNA REPAIR AND RECOMBINATION PROTEIN RADA; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PYROCOCCUS FURIOSUS; SOURCE 3 ORGANISM_TAXID: 2261; SOURCE 4 STRAIN: ATCC 43587 / DSM 3638 / JCM 8422 / VC1; SOURCE 5 GENE: RADA, PF1926; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PBAT4 KEYWDS DNA REPAIR, FRAGMENT BASED DRUG DESIGN, HUMANISATION, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR G.FISCHER,M.MARSH,T.MOSCHETTI,T.SHARPE,D.SCOTT,M.MORGAN,H.NG, AUTHOR 2 J.SKIDMORE,A.VENKITARAMAN,C.ABELL,T.L.BLUNDELL,M.HYVONEN REVDAT 3 07-FEB-24 5JED 1 REMARK REVDAT 2 30-NOV-16 5JED 1 JRNL REVDAT 1 19-OCT-16 5JED 0 JRNL AUTH T.MOSCHETTI,T.SHARPE,G.FISCHER,M.E.MARSH,H.K.NG,M.MORGAN, JRNL AUTH 2 D.E.SCOTT,T.L.BLUNDELL,A.R VENKITARAMAN,J.SKIDMORE,C.ABELL, JRNL AUTH 3 M.HYVONEN JRNL TITL ENGINEERING ARCHEAL SURROGATE SYSTEMS FOR THE DEVELOPMENT OF JRNL TITL 2 PROTEIN-PROTEIN INTERACTION INHIBITORS AGAINST HUMAN RAD51. JRNL REF J.MOL.BIOL. V. 428 4589 2016 JRNL REFN ESSN 1089-8638 JRNL PMID 27725183 JRNL DOI 10.1016/J.JMB.2016.10.009 REMARK 2 REMARK 2 RESOLUTION. 1.33 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0124 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.33 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 43497 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.137 REMARK 3 R VALUE (WORKING SET) : 0.135 REMARK 3 FREE R VALUE : 0.171 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2263 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.33 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.37 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3201 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.38 REMARK 3 BIN R VALUE (WORKING SET) : 0.3320 REMARK 3 BIN FREE R VALUE SET COUNT : 148 REMARK 3 BIN FREE R VALUE : 0.3760 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1784 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 22 REMARK 3 SOLVENT ATOMS : 201 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.22 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.11000 REMARK 3 B22 (A**2) : -1.59000 REMARK 3 B33 (A**2) : 0.29000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.30000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.055 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.052 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.041 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.353 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.980 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.971 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1987 ; 0.012 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 1927 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2706 ; 1.579 ; 1.966 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4416 ; 0.958 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 263 ; 6.013 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 93 ;31.871 ;23.548 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 348 ;11.988 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;16.119 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 300 ; 0.099 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2359 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 481 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1007 ; 1.815 ; 1.734 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1006 ; 1.813 ; 1.732 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1285 ; 2.237 ; 2.614 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1286 ; 2.236 ; 2.615 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 980 ; 2.900 ; 2.237 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 981 ; 2.899 ; 2.240 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1422 ; 3.504 ; 3.195 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2342 ; 4.291 ;16.270 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2258 ; 3.602 ;15.509 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 3914 ; 2.200 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 46 ;32.218 ; 5.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 4027 ;13.175 ; 5.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5JED COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-APR-16. REMARK 100 THE DEPOSITION ID IS D_1000220445. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-FEB-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96862 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45801 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.332 REMARK 200 RESOLUTION RANGE LOW (A) : 37.720 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.09300 REMARK 200 R SYM (I) : 0.10300 REMARK 200 FOR THE DATA SET : 7.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.33 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 1.08600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5J4L REMARK 200 REMARK 200 REMARK: RODS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M NACACODYLATE PH=6.5, 5% PEG8000, REMARK 280 40% MPD, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.05000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -41.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 107 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 118 CD CE NZ REMARK 470 LYS A 122 CE NZ REMARK 470 GLU A 274 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 344 O HOH A 501 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 227 43.98 -106.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MPD A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MRD A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 404 DBREF 5JED A 108 349 UNP O74036 RADA_PYRFU 108 349 SEQADV 5JED MET A 107 UNP O74036 INITIATING METHIONINE SEQADV 5JED LYS A 167 UNP O74036 SER 167 ENGINEERED MUTATION SEQADV 5JED ALA A 168 UNP O74036 VAL 168 ENGINEERED MUTATION SEQADV 5JED MET A 169 UNP O74036 ILE 169 ENGINEERED MUTATION SEQADV 5JED TYR A 170 UNP O74036 TRP 170 ENGINEERED MUTATION SEQADV 5JED LEU A 182 UNP O74036 ILE 182 ENGINEERED MUTATION SEQADV 5JED ASP A 198 UNP O74036 LYS 198 ENGINEERED MUTATION SEQADV 5JED ASN A 199 UNP O74036 HIS 199 ENGINEERED MUTATION SEQADV 5JED VAL A 200 UNP O74036 ILE 200 ENGINEERED MUTATION SEQADV 5JED ALA A 201 UNP O74036 TYR 201 ENGINEERED MUTATION SEQADV 5JED TYR A 202 UNP O74036 VAL 202 ENGINEERED MUTATION SEQADV 5JED GLN A 213 UNP O74036 LEU 213 ENGINEERED MUTATION SEQADV 5JED LEU A 215 UNP O74036 VAL 215 ENGINEERED MUTATION SEQADV 5JED TYR A 216 UNP O74036 GLN 216 ENGINEERED MUTATION SEQADV 5JED SER A 219 UNP O74036 GLU 219 ENGINEERED MUTATION SEQADV 5JED MET A 221 UNP O74036 LYS 221 ENGINEERED MUTATION SEQADV 5JED MET A 222 UNP O74036 ILE 222 ENGINEERED MUTATION SEQADV 5JED VAL A 223 UNP O74036 LYS 223 ENGINEERED MUTATION SEQADV 5JED SER A 225 UNP O74036 LEU 225 ENGINEERED MUTATION SEQADV 5JED TYR A 232 UNP O74036 VAL 232 ENGINEERED MUTATION SEQADV 5JED ARG A 263 UNP O74036 LYS 263 ENGINEERED MUTATION SEQADV 5JED PHE A 264 UNP O74036 HIS 264 ENGINEERED MUTATION SEQADV 5JED ARG A 266 UNP O74036 ALA 266 ENGINEERED MUTATION SEQADV 5JED MET A 267 UNP O74036 ASP 267 ENGINEERED MUTATION SEQADV 5JED GLU A 274 UNP O74036 LEU 274 ENGINEERED MUTATION SEQADV 5JED PHE A 275 UNP O74036 TYR 275 ENGINEERED MUTATION SEQADV 5JED A UNP O74036 ARG 288 DELETION SEQADV 5JED A UNP O74036 PRO 289 DELETION SEQADV 5JED A UNP O74036 ASP 290 DELETION SEQADV 5JED A UNP O74036 ALA 291 DELETION SEQADV 5JED A UNP O74036 PHE 292 DELETION SEQADV 5JED A UNP O74036 PHE 293 DELETION SEQADV 5JED A UNP O74036 GLY 294 DELETION SEQADV 5JED A UNP O74036 ASP 295 DELETION SEQADV 5JED A UNP O74036 PRO 296 DELETION SEQADV 5JED A UNP O74036 THR 297 DELETION SEQADV 5JED A UNP O74036 ARG 298 DELETION SEQADV 5JED A UNP O74036 PRO 299 DELETION SEQADV 5JED ASN A 288 UNP O74036 ILE 300 ENGINEERED MUTATION SEQRES 1 A 231 MET ALA THR ILE GLY ARG ILE SER THR GLY SER LYS SER SEQRES 2 A 231 LEU ASP LYS LEU LEU GLY GLY GLY ILE GLU THR GLN ALA SEQRES 3 A 231 ILE THR GLU VAL PHE GLY GLU PHE GLY SER GLY LYS THR SEQRES 4 A 231 GLN LEU ALA HIS THR LEU ALA VAL MET VAL GLN LEU PRO SEQRES 5 A 231 PRO GLU GLU GLY GLY LEU ASN GLY LYS ALA MET TYR ILE SEQRES 6 A 231 ASP THR GLU ASN THR PHE ARG PRO GLU ARG LEU ARG GLU SEQRES 7 A 231 ILE ALA GLN ASN ARG GLY LEU ASP PRO ASP GLU VAL LEU SEQRES 8 A 231 ASP ASN VAL ALA TYR ALA ARG ALA PHE ASN SER ASN HIS SEQRES 9 A 231 GLN MET GLN LEU LEU TYR GLN ALA SER ASP MET MET VAL SEQRES 10 A 231 GLU SER LEU ASN THR ASP ARG PRO TYR LYS LEU LEU ILE SEQRES 11 A 231 VAL ASP SER LEU THR SER HIS PHE ARG SER GLU TYR ILE SEQRES 12 A 231 GLY ARG GLY ALA LEU ALA GLU ARG GLN GLN LYS LEU ALA SEQRES 13 A 231 ARG PHE LEU ARG MET LEU HIS ARG LEU ALA ASN GLU PHE SEQRES 14 A 231 ASP ILE ALA VAL PHE VAL THR ASN GLN VAL GLN ALA ASN SEQRES 15 A 231 GLY GLY HIS ILE LEU ALA HIS SER ALA THR LEU ARG VAL SEQRES 16 A 231 TYR LEU ARG LYS GLY LYS GLY GLY LYS ARG ILE ALA ARG SEQRES 17 A 231 LEU ILE ASP ALA PRO HIS LEU PRO GLU GLY GLU ALA VAL SEQRES 18 A 231 PHE SER ILE THR GLU LYS GLY ILE GLU ASP HET SO4 A 401 5 HET MPD A 402 8 HET MRD A 403 8 HET CL A 404 1 HETNAM SO4 SULFATE ION HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETNAM MRD (4R)-2-METHYLPENTANE-2,4-DIOL HETNAM CL CHLORIDE ION FORMUL 2 SO4 O4 S 2- FORMUL 3 MPD C6 H14 O2 FORMUL 4 MRD C6 H14 O2 FORMUL 5 CL CL 1- FORMUL 6 HOH *201(H2 O) HELIX 1 AA1 SER A 117 LEU A 124 1 8 HELIX 2 AA2 GLY A 143 VAL A 155 1 13 HELIX 3 AA3 GLN A 156 LEU A 157 5 2 HELIX 4 AA4 PRO A 158 GLY A 162 5 5 HELIX 5 AA5 ARG A 178 ARG A 189 1 12 HELIX 6 AA6 ASP A 192 ASN A 199 1 8 HELIX 7 AA7 ASN A 207 LEU A 226 1 20 HELIX 8 AA8 THR A 241 TYR A 248 1 8 HELIX 9 AA9 GLY A 250 ASP A 276 1 27 SHEET 1 AA1 2 ARG A 112 ILE A 113 0 SHEET 2 AA1 2 ILE A 128 GLU A 129 -1 O ILE A 128 N ILE A 113 SHEET 1 AA2 9 VAL A 200 ARG A 204 0 SHEET 2 AA2 9 LYS A 167 ASP A 172 1 N TYR A 170 O ALA A 201 SHEET 3 AA2 9 TYR A 232 ASP A 238 1 O ILE A 236 N ILE A 171 SHEET 4 AA2 9 ALA A 278 GLN A 284 1 O PHE A 280 N LEU A 235 SHEET 5 AA2 9 ALA A 132 GLY A 138 1 N THR A 134 O VAL A 279 SHEET 6 AA2 9 LEU A 311 LYS A 317 1 O LEU A 311 N GLU A 135 SHEET 7 AA2 9 ARG A 323 ILE A 328 -1 O ILE A 324 N ARG A 316 SHEET 8 AA2 9 GLY A 336 THR A 343 -1 O PHE A 340 N ARG A 323 SHEET 9 AA2 9 GLY A 346 GLU A 348 -1 O GLU A 348 N SER A 341 CISPEP 1 ASP A 238 SER A 239 0 16.22 SITE 1 AC1 12 GLU A 139 PHE A 140 GLY A 141 SER A 142 SITE 2 AC1 12 GLY A 143 LYS A 144 THR A 145 HOH A 538 SITE 3 AC1 12 HOH A 539 HOH A 556 HOH A 587 HOH A 634 SITE 1 AC2 8 GLU A 135 LEU A 240 LEU A 261 ASN A 283 SITE 2 AC2 8 ILE A 292 ARG A 312 HOH A 542 HOH A 649 SITE 1 AC3 7 SER A 114 LYS A 118 ASP A 121 MET A 154 SITE 2 AC3 7 GLU A 161 GLY A 162 HOH A 505 SITE 1 AC4 2 HIS A 269 ALA A 297 CRYST1 37.771 72.100 41.927 90.00 115.89 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026475 0.000000 0.012848 0.00000 SCALE2 0.000000 0.013870 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026511 0.00000